Allogene Therapeutics, Inc. (ALLO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -12.91M | -27.6M | -29.69M | -39.03M | -52.93M | -36.7M | -44.12M | -63.59M | -55.9M | -53.71M | -55.53M | -61.86M | -66.64M | -62.1M | -47.66M | -42.53M | -68.24M | -45.44M | -48.88M | -41.17M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | -254086.36% | 122061.36% | -252409.09% | -281168.18% | -222130% | -132119.15% | -97255.1% | -49454.65% | -111863.93% | -89090.2% | -99751.02% | -93568.18% |
| Operating CF Growth % | 75.6% | 24.79% | 32.7% | 38.62% | 5.31% | 31.67% | 20.56% | -2.8% | 16.12% | 13.51% | -16.53% | -45.44% | 2.34% | -36.67% | 2.5% | -3.31% | -38.33% | -355.5% | -30.04% | -54.07% |
| Net Income | -42.61M | -38.81M | -41.4M | -50.94M | -59.73M | -59.94M | -66.29M | -66.36M | -65M | -89.26M | -61.31M | -79.23M | -99.97M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M | -70.94M |
| Depreciation & Amortization | 2.87M | 3.06M | 3.1M | 3.11M | 3.1M | 3.23M | 3.21M | 3.64M | 3.56M | 3.48M | 3.57M | 3.64M | 3.51M | 3.31M | 3.86M | 4.85M | 4.16M | 4.24M | 2.56M | 2.35M |
| Stock-Based Compensation | 0 | 8.13M | 8.65M | 8.69M | 12.18M | 12.87M | 13.39M | 13.56M | 11.92M | 15.23M | 15.35M | 16.59M | 18.77M | 0 | 21.15M | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.17M | 1.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 8.45M | 226K | 108K | 2.36M | -176K | 1.86M | -15.61M | 2.32M | -1.94M | 75K | 147K | 1.5M | 3.63M | 18.63M | 2.7M | 22.31M | 27.45M | 25.16M | 23.38M | 23.5M |
| Working Capital Changes | 18.37M | -202K | -145K | -2.24M | -8.29M | 5.27M | 21.19M | -16.75M | -4.44M | -3.4M | -14.89M | -4.36M | 7.42M | 10.81M | 7.79M | 5.1M | -19.99M | 33K | 3.37M | 3.91M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 663K | 599K | -1.07M | -422K | -336K | 34K | -7.23M | 6.81M | -118K | -302K | -3.97M | -4.29M | 1.06M | 2.94M | 1.01M | 1.42M | -505K | -2.04M | 189K | -3.06M |
| Cash from Investing | -29.59M | 33.61M | 11.94M | 43.84M | 6.18M | 54.93M | -75.99M | 74.61M | 22.13M | 67.46M | -34.27M | 17.16M | 112.94M | 49.6M | 24.91M | 54.03M | -22.38M | 29.25M | 13.01M | 24.59M |
| Capital Expenditures | -9K | 0 | -243K | -44K | -99K | -257K | -429K | 0 | -8K | -181K | -12K | -288K | -1.03M | -1.69M | -223K | -1.37M | -1.9M | -736K | -3.35M | -10.9M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 36.36% | -411.36% | 54.55% | 1309.09% | 3450% | 3600% | 455.1% | 1597.67% | 3118.03% | 1443.14% | 6830.61% | 24777.27% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -67.64M | 34.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67.64M | -34.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 21.12M | 7.86M | 3.24M | 5.07M | 13.99M | 5.74M | 679K | 108.6M | 1.65M | 155K | 4.29M | 89.52M | 1.73M | 46K | 1.07M | 24K | 1.81M | 322K | 2.38M | 3.21M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 21.12M | 7.86M | 3.24M | 1.51M | 10M | 5.74M | 679K | 106.3M | 1.65M | 155K | 3.19M | 89.52M | 0 | 46K | 0 | 24K | 1.81M | 322K | 2.38M | 3.21M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 3.56M | 3.99M | 0 | 0 | 2.3M | 0 | 0 | 1.09M | 0 | 1.73M | 0 | 1.07M | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -21.38M | 13.87M | -14.52M | 9.88M | -32.76M | 23.98M | -119.43M | 119.63M | -32.12M | 13.91M | -85.51M | 44.83M | 48.03M | -12.45M | -21.68M | 11.53M | -88.8M | -16.71M | -33.48M | -13.36M |
| Free Cash Flow | -12.92M | -27.6M | -29.93M | -39.07M | -53.03M | -36.95M | -44.54M | -63.59M | -55.91M | -53.89M | -55.54M | -62.15M | -67.67M | -63.79M | -47.88M | -43.91M | -70.14M | -46.17M | -52.23M | -52.07M |
| FCF Margin % | - | - | - | - | - | - | - | - | -254122.73% | 122472.73% | -252463.64% | -282477.27% | -225580% | -135719.15% | -97710.2% | -51052.33% | -114981.97% | -90533.33% | -106581.63% | -118345.45% |
| FCF Growth % | 75.63% | 25.32% | 32.81% | 38.55% | 5.15% | 31.42% | 19.8% | -2.32% | 17.39% | 15.52% | -16.01% | -41.54% | 3.51% | -38.15% | 8.32% | 15.68% | -25.72% | -68.64% | 9.7% | -21.73% |
| FCF per Share | -0.05 | -0.13 | -0.13 | -0.18 | -0.25 | -0.18 | -0.21 | -0.33 | -0.33 | -0.32 | -0.33 | -0.42 | -0.47 | -0.44 | -0.33 | -0.31 | -0.50 | -0.33 | -0.38 | -0.39 |
| FCF Conversion (FCF/Net Income) | 0.30x | 0.71x | 0.72x | 0.77x | 0.89x | 0.61x | 0.67x | 0.96x | 0.86x | 0.60x | 0.89x | 0.78x | 0.67x | 0.65x | 0.57x | 0.57x | 0.85x | 0.61x | 0.63x | 0.58x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |